TY - JOUR
T1 - Testing and tracking in the UK
T2 - A dynamic causal modelling study
AU - Friston, Karl J.
AU - Parr, Thomas
AU - Zeidman, Peter
AU - Razi, Adeel
AU - Flandin, Guillaume
AU - Daunizeau, Jean
AU - Hulme, Oliver J.
AU - Billig, Alexander J.
AU - Litvak, Vladimir
AU - Price, Cathy J.
AU - Moran, Rosalyn J.
AU - Lambert, Christian
N1 - Funding Information:
Grant information: This work was supported by Wellcome through core funding to the Wellcome Centre for Human Neuroimaging, UCL Queen Square Institute of Neurology [203147]; and a Principle Research Fellowship grant to KJF [088130]. AJB is supported by a Wellcome Trust grant [091681]. AR is funded by the Australian Research Council [Refs: DE170100128 and DP200100757]. CL is supported by an MRC Clinician Scientist award [MR/R006504/1].
Publisher Copyright:
© 2020. Friston KJ et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020
Y1 - 2020
N2 - By equipping a previously reported dynamic causal modelling of COVID-19 with an isolation state, we were able to model the effects of self-isolation consequent on testing and tracking. Specifically, we included a quarantine or isolation state occupied by people who believe they might be infected but are asymptomatic—and could only leave if they test negative. We recovered maximum posteriori estimates of the model parameters using time series of new cases, daily deaths, and tests for the UK. These parameters were used to simulate the trajectory of the outbreak in the UK over an 18-month period. Several clear-cut conclusions emerged from these simulations. For example, under plausible (graded) relaxations of social distancing, a rebound of infections is highly unlikely. The emergence of a second wave depends almost exclusively on the rate at which we lose immunity, inherited from the first wave. There exists no testing strategy that can attenuate mortality rates, other than by deferring or delaying a second wave. A testing and tracking policy—implemented at the present time—will defer any second wave beyond a time horizon of 18 months. Crucially, this deferment is within current testing capabilities (requiring an efficacy of tracing and tracking of about 20% of asymptomatic infected cases, with 50,000 tests per day). These conclusions are based upon a dynamic causal model for which we provide some construct and face validation—using a comparative analysis of the United Kingdom and Germany, supplemented with recent serological studies.
AB - By equipping a previously reported dynamic causal modelling of COVID-19 with an isolation state, we were able to model the effects of self-isolation consequent on testing and tracking. Specifically, we included a quarantine or isolation state occupied by people who believe they might be infected but are asymptomatic—and could only leave if they test negative. We recovered maximum posteriori estimates of the model parameters using time series of new cases, daily deaths, and tests for the UK. These parameters were used to simulate the trajectory of the outbreak in the UK over an 18-month period. Several clear-cut conclusions emerged from these simulations. For example, under plausible (graded) relaxations of social distancing, a rebound of infections is highly unlikely. The emergence of a second wave depends almost exclusively on the rate at which we lose immunity, inherited from the first wave. There exists no testing strategy that can attenuate mortality rates, other than by deferring or delaying a second wave. A testing and tracking policy—implemented at the present time—will defer any second wave beyond a time horizon of 18 months. Crucially, this deferment is within current testing capabilities (requiring an efficacy of tracing and tracking of about 20% of asymptomatic infected cases, with 50,000 tests per day). These conclusions are based upon a dynamic causal model for which we provide some construct and face validation—using a comparative analysis of the United Kingdom and Germany, supplemented with recent serological studies.
KW - Bayesian
KW - compartmental models
KW - coronavirus
KW - dynamic causal modelling
KW - epidemiology
KW - variational
UR - https://www.scopus.com/pages/publications/85117892909
U2 - 10.12688/WELLCOMEOPENRES.16004.1
DO - 10.12688/WELLCOMEOPENRES.16004.1
M3 - Article
AN - SCOPUS:85117892909
SN - 2398-502X
VL - 5
JO - Wellcome Open Research
JF - Wellcome Open Research
ER -